Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease
Dawn A. Brooks, Yuma Yokoi, Sergey Shcherbinin, Oskar Hansson et al.
Citations
4 citations
Journal
JAMA Neurology
Topics
Alzheimer's disease research and treatments
Field-Weighted Citation Impact (FWCI)
4.66
article
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease
Dawn A. Brooks, Yuma Yokoi, Sergey Shcherbinin, Oskar Hansson, Emily C. Collins, Mark A. Mintun, Amy K. Ellinwood, Min Jung Kim, Ming Lu, John R. Sims, David S. Knopman